Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 15 | 2025 | 594 | 2.180 |
Why?
|
| Protein Kinase C | 14 | 2021 | 124 | 1.880 |
Why?
|
| Memory Disorders | 3 | 2023 | 77 | 1.460 |
Why?
|
| Alzheimer Disease | 6 | 2025 | 1001 | 1.050 |
Why?
|
| Memory | 10 | 2018 | 174 | 0.970 |
Why?
|
| Prostaglandin D2 | 3 | 2022 | 26 | 0.810 |
Why?
|
| Dendritic Spines | 4 | 2018 | 35 | 0.750 |
Why?
|
| Long-Term Potentiation | 10 | 2016 | 109 | 0.710 |
Why?
|
| Amygdala | 6 | 2021 | 125 | 0.700 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2021 | 69 | 0.680 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2019 | 17 | 0.620 |
Why?
|
| Receptors, AMPA | 8 | 2019 | 58 | 0.620 |
Why?
|
| Central Nervous System Stimulants | 1 | 2021 | 180 | 0.610 |
Why?
|
| Methamphetamine | 1 | 2021 | 166 | 0.610 |
Why?
|
| Rats | 22 | 2025 | 3735 | 0.590 |
Why?
|
| Maze Learning | 4 | 2021 | 113 | 0.560 |
Why?
|
| Animals | 39 | 2025 | 16992 | 0.550 |
Why?
|
| Brain | 10 | 2025 | 1472 | 0.480 |
Why?
|
| Rats, Transgenic | 6 | 2025 | 34 | 0.460 |
Why?
|
| Disease Models, Animal | 10 | 2025 | 1596 | 0.400 |
Why?
|
| Male | 29 | 2025 | 23409 | 0.400 |
Why?
|
| Stress, Physiological | 1 | 2013 | 172 | 0.370 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2018 | 1766 | 0.350 |
Why?
|
| Mental Recall | 3 | 2016 | 84 | 0.330 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 141 | 0.300 |
Why?
|
| Memory, Short-Term | 3 | 2021 | 59 | 0.290 |
Why?
|
| Mice | 7 | 2023 | 6644 | 0.290 |
Why?
|
| Fear | 3 | 2019 | 272 | 0.280 |
Why?
|
| Dopamine | 2 | 2021 | 275 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 1869 | 0.280 |
Why?
|
| Membrane Proteins | 3 | 2025 | 561 | 0.280 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 81 | 0.260 |
Why?
|
| Conditioning, Classical | 3 | 2019 | 67 | 0.250 |
Why?
|
| Female | 17 | 2025 | 24698 | 0.240 |
Why?
|
| Estradiol | 2 | 2018 | 268 | 0.240 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 192 | 0.240 |
Why?
|
| Animals, Newborn | 3 | 2018 | 352 | 0.240 |
Why?
|
| Avoidance Learning | 6 | 2017 | 70 | 0.230 |
Why?
|
| Isoenzymes | 2 | 2008 | 168 | 0.230 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 252 | 0.230 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2017 | 35 | 0.220 |
Why?
|
| Opioid-Related Disorders | 1 | 2008 | 195 | 0.220 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2025 | 46 | 0.220 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 665 | 0.220 |
Why?
|
| Sex Factors | 2 | 2021 | 1028 | 0.210 |
Why?
|
| Pyramidal Cells | 4 | 2011 | 65 | 0.210 |
Why?
|
| Chalcones | 1 | 2024 | 17 | 0.210 |
Why?
|
| Rats, Inbred F344 | 4 | 2025 | 258 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 185 | 0.200 |
Why?
|
| Indolizines | 1 | 2023 | 7 | 0.200 |
Why?
|
| Ubiquitins | 1 | 2023 | 47 | 0.200 |
Why?
|
| Excitatory Postsynaptic Potentials | 6 | 2016 | 80 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 65 | 0.190 |
Why?
|
| Chickens | 5 | 1995 | 161 | 0.190 |
Why?
|
| Pyrazoles | 1 | 2023 | 103 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2023 | 116 | 0.180 |
Why?
|
| Behavior, Animal | 2 | 2021 | 373 | 0.180 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2021 | 23 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 159 | 0.170 |
Why?
|
| Administration, Oral | 1 | 2021 | 260 | 0.170 |
Why?
|
| Anorexia Nervosa | 1 | 2020 | 6 | 0.160 |
Why?
|
| Microglia | 2 | 2019 | 208 | 0.160 |
Why?
|
| Corticosterone | 3 | 2017 | 90 | 0.160 |
Why?
|
| Neurons | 4 | 2019 | 1263 | 0.150 |
Why?
|
| Maternal Behavior | 1 | 2019 | 29 | 0.150 |
Why?
|
| Stress, Psychological | 2 | 2017 | 661 | 0.150 |
Why?
|
| Leupeptins | 1 | 2018 | 12 | 0.140 |
Why?
|
| Gene Expression | 4 | 2018 | 701 | 0.140 |
Why?
|
| Substantia Nigra | 1 | 2018 | 52 | 0.140 |
Why?
|
| Encephalitis | 1 | 2018 | 43 | 0.140 |
Why?
|
| Dominance-Subordination | 1 | 2017 | 6 | 0.130 |
Why?
|
| Pseudopodia | 1 | 2017 | 17 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2018 | 125 | 0.130 |
Why?
|
| Inflammation | 1 | 2023 | 758 | 0.130 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2017 | 6 | 0.130 |
Why?
|
| Phenanthridines | 2 | 2002 | 4 | 0.130 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2013 | 23 | 0.120 |
Why?
|
| Estrogens | 1 | 2017 | 203 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2017 | 187 | 0.120 |
Why?
|
| Neuronal Plasticity | 4 | 2019 | 126 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 269 | 0.120 |
Why?
|
| Benzophenanthridines | 3 | 2008 | 14 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 200 | 0.110 |
Why?
|
| Appetitive Behavior | 1 | 1995 | 16 | 0.110 |
Why?
|
| Rats, Long-Evans | 4 | 2019 | 108 | 0.110 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2014 | 1 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2025 | 2157 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 423 | 0.110 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1994 | 41 | 0.100 |
Why?
|
| Golgi Apparatus | 1 | 2013 | 27 | 0.100 |
Why?
|
| Learning | 3 | 2018 | 161 | 0.100 |
Why?
|
| Nerve Net | 1 | 2014 | 101 | 0.100 |
Why?
|
| Aging | 3 | 2016 | 783 | 0.100 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 42 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 863 | 0.090 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2011 | 20 | 0.090 |
Why?
|
| Functional Laterality | 3 | 2018 | 89 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 934 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 420 | 0.080 |
Why?
|
| Phenols | 1 | 2011 | 107 | 0.080 |
Why?
|
| Ethanol | 1 | 2013 | 224 | 0.080 |
Why?
|
| Emetine | 2 | 2005 | 14 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 3 | 2005 | 228 | 0.070 |
Why?
|
| N-Ethylmaleimide-Sensitive Proteins | 1 | 2008 | 1 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 1180 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 1542 | 0.070 |
Why?
|
| Methadyl Acetate | 1 | 2008 | 1 | 0.070 |
Why?
|
| Receptor, trkB | 1 | 2008 | 20 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 153 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2005 | 986 | 0.070 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2008 | 126 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 456 | 0.060 |
Why?
|
| Phenotype | 2 | 2020 | 780 | 0.060 |
Why?
|
| Anisomycin | 1 | 2005 | 8 | 0.060 |
Why?
|
| Anxiety | 1 | 2013 | 874 | 0.060 |
Why?
|
| Dendrites | 1 | 2005 | 57 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 159 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2005 | 219 | 0.050 |
Why?
|
| Diazoxide | 1 | 2024 | 5 | 0.050 |
Why?
|
| Humans | 9 | 2022 | 43102 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2014 | 137 | 0.050 |
Why?
|
| Olfactory Bulb | 2 | 1995 | 50 | 0.050 |
Why?
|
| Pregnancy | 2 | 2008 | 1772 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2002 | 135 | 0.050 |
Why?
|
| Receptors, Prostaglandin | 1 | 2022 | 7 | 0.050 |
Why?
|
| Presenilin-1 | 1 | 2022 | 28 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2005 | 321 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2005 | 307 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2022 | 23 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2022 | 64 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2022 | 95 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 73 | 0.050 |
Why?
|
| Canada | 1 | 2021 | 163 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2003 | 1271 | 0.040 |
Why?
|
| Time Factors | 4 | 2006 | 1857 | 0.040 |
Why?
|
| Anorexia | 1 | 2020 | 5 | 0.040 |
Why?
|
| GAP-43 Protein | 1 | 2000 | 9 | 0.040 |
Why?
|
| Social Behavior | 1 | 2021 | 161 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2000 | 48 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2000 | 93 | 0.040 |
Why?
|
| Alkaloids | 2 | 2002 | 46 | 0.040 |
Why?
|
| Electric Stimulation | 3 | 2006 | 186 | 0.040 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2019 | 13 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 33 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2018 | 34 | 0.040 |
Why?
|
| Ventral Tegmental Area | 1 | 2019 | 49 | 0.040 |
Why?
|
| Calpain | 1 | 2018 | 35 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 78 | 0.040 |
Why?
|
| Parkinsonian Disorders | 1 | 2018 | 42 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 92 | 0.040 |
Why?
|
| Rodentia | 1 | 2018 | 47 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 139 | 0.030 |
Why?
|
| Chlordiazepoxide | 1 | 2017 | 1 | 0.030 |
Why?
|
| Taste Perception | 1 | 2017 | 3 | 0.030 |
Why?
|
| Ketamine | 1 | 2017 | 13 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 17 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2017 | 37 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 146 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2017 | 56 | 0.030 |
Why?
|
| Sp4 Transcription Factor | 1 | 2017 | 1 | 0.030 |
Why?
|
| Sarcoglycans | 1 | 2017 | 4 | 0.030 |
Why?
|
| Finland | 1 | 2017 | 15 | 0.030 |
Why?
|
| Germany | 1 | 2017 | 26 | 0.030 |
Why?
|
| Dystrophin | 1 | 2017 | 20 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 65 | 0.030 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2016 | 13 | 0.030 |
Why?
|
| Olfactory Perception | 1 | 2016 | 6 | 0.030 |
Why?
|
| Visual Perception | 1 | 2017 | 80 | 0.030 |
Why?
|
| Brazil | 1 | 2017 | 84 | 0.030 |
Why?
|
| Predatory Behavior | 1 | 2016 | 23 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2017 | 104 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 570 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 1124 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 93 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 2016 | 90 | 0.030 |
Why?
|
| Injections | 1 | 1995 | 42 | 0.030 |
Why?
|
| Neostriatum | 1 | 1995 | 28 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 429 | 0.030 |
Why?
|
| Angiomyolipoma | 1 | 1994 | 2 | 0.030 |
Why?
|
| Staurosporine | 2 | 2006 | 38 | 0.030 |
Why?
|
| Motor Activity | 1 | 2017 | 437 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1994 | 3 | 0.030 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1994 | 10 | 0.030 |
Why?
|
| Amnesia | 1 | 1994 | 8 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 800 | 0.030 |
Why?
|
| Bradykinin | 1 | 1994 | 25 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1993 | 13 | 0.030 |
Why?
|
| Brain Stem | 1 | 1994 | 52 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2014 | 59 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 1995 | 121 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2014 | 138 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 1994 | 80 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1994 | 141 | 0.030 |
Why?
|
| Arteriosclerosis | 2 | 1971 | 43 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1285 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1993 | 100 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 734 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 174 | 0.020 |
Why?
|
| Receptors, GABA | 1 | 2013 | 28 | 0.020 |
Why?
|
| Ouabain | 1 | 1992 | 15 | 0.020 |
Why?
|
| Glutamates | 1 | 1992 | 23 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 1612 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1992 | 58 | 0.020 |
Why?
|
| Calcium | 1 | 1994 | 491 | 0.020 |
Why?
|
| Benzhydryl Compounds | 1 | 2011 | 50 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1992 | 131 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1971 | 48 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1971 | 70 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 883 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1971 | 102 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 587 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1971 | 123 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1019 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 283 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 296 | 0.020 |
Why?
|
| Perforant Pathway | 1 | 2006 | 15 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2006 | 40 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 57 | 0.020 |
Why?
|
| Child | 1 | 2014 | 3443 | 0.010 |
Why?
|
| United States | 1 | 2017 | 5205 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 863 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 6081 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 20 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 101 | 0.010 |
Why?
|
| Sirolimus | 1 | 2005 | 70 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2003 | 88 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2003 | 118 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 196 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 240 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 132 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 423 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2003 | 136 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 983 | 0.010 |
Why?
|
| Time | 1 | 2000 | 15 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 109 | 0.010 |
Why?
|
| Xenopus | 1 | 2000 | 48 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 138 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2000 | 92 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 458 | 0.010 |
Why?
|
| Oocytes | 1 | 2000 | 149 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 532 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 300 | 0.010 |
Why?
|
| Hypercholesterolemia | 2 | 1971 | 42 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1994 | 16 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1994 | 48 | 0.010 |
Why?
|
| Cytosol | 1 | 1994 | 97 | 0.010 |
Why?
|
| Biological Transport | 1 | 1994 | 204 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1994 | 141 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1971 | 26 | 0.010 |
Why?
|
| Triglycerides | 1 | 1971 | 147 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1994 | 1621 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1971 | 148 | 0.000 |
Why?
|
| Adult | 2 | 1994 | 13872 | 0.000 |
Why?
|
| Androstanols | 1 | 1964 | 1 | 0.000 |
Why?
|
| Xanthomatosis | 1 | 1964 | 5 | 0.000 |
Why?
|
| Pharmacology | 1 | 1964 | 6 | 0.000 |
Why?
|
| Anabolic Agents | 1 | 1964 | 20 | 0.000 |
Why?
|
| Steroids | 1 | 1964 | 45 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1964 | 123 | 0.000 |
Why?
|
| Aged | 1 | 1971 | 8214 | 0.000 |
Why?
|
| Middle Aged | 1 | 1971 | 12222 | 0.000 |
Why?
|